This compound is a chiral pharmaceutical intermediate specifically used in the manufacturing process of darolutamide. It features a pyrazole ring substituted with an aminopropyl group and a chlorobenzonitrile moiety.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
3-acetyl-1H-pyrazole-5-carboxylic acid
pharmaceutical intermediate
Di-tert-butyl (2-oxopropane-1,3-diyl)dicarbamate
pharmaceutical intermediate
Cis-3,5-Dimethylpiperazine-1-carboxylic acid tert-butyl ester
pharmaceutical intermediate
Ethyl Piperazine-2-carboxylate Dihydrochloride
pharmaceutical intermediate
Tert-Butyl (S)-(1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)carbamate
pharmaceutical intermediate
Celecoxib N-des(benzenesulfonamide)
pharmaceutical intermediate
2-chloro-4-(1H-pyrazol-5-yl)benzonitrile
pharmaceutical intermediate
4-[1-[(2S)-2-aminopropyl]pyrazol-3-yl]-2-chlorobenzonitrile
MQWGPHFTKXGETE-VIFPVBQESA-N
C[C@@H](CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)N
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.